ADVERSE REACTIONS The following serious adverse reactions are described below or elsewhere in the prescribing information: Risk of Thyroid C-cell Tumors [see Warnings and Precautions (5.1 )] Acute Pancreatitis [see Warnings and Precautions (5.2) ] Diabetic Retinopathy Complications [see Warnings and Precautions (5.3 )] Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin [see Warnings and Precautions (5.5 )] Acute Kidney Injury Due to Volume Depletion [see Warnings and Precautions (5.6 )] Severe Gastrointestinal Adverse Reactions [see Warnings and Precautions (5.7 )] Hypersensitivity Reactions [see Warnings and Precautions ( 5.8 )] Acute Gallbladder Disease [see Warnings and Precautions (5.9 )] Pulmonary Aspiration During General Anesthesia or Deep Sedation [see Warnings and Precautions (5.10 )] Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice
Sensible Follow-Up: Attend all scheduled follow-up appointments to monitor progress and make necessary adjustments to your treatment plan
Restraints Impact Analysis of Anti-obesity Drugs Market * Manufacturing-Capacity Bottlenecks for Complex Peptide APIs Solid-phase peptide synthesis, HPLC purification, and lyophilization create long cycle times that cap throughput
The transition will be carefully planned, including any necessary washout period, dose adjustments, and monitoring to ensure safety and effectiveness
While they lower A1C by about 0.5% to 1%, their real superpower is protecting your organs
It remains, however, a preclinical characterisation
